Home LiteratureArticle Details
PMID: 6095274 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.

Hennessy K, Fennewald S, Hummel M, Cole T, Kieff E

Abstract

The nucleotide sequence of an Epstein-Barr virus gene expressed in latently infected growth-transformed cells is known to include a long open reading frame containing a 33-base-pair repeat element. A bacterial fusion protein constructed from a portion of the reading frame and Escherichia coli beta-galactosidase was used to produce sera in rabbits against the previously unidentified gene product. The viral protein detected with these sera in latently infected cells varies in size with the number of copies of the DNA repeat element. Translation of the RNA in vitro yields a protein of similar size. As expected from its primary sequence, the protein is a membrane protein. Immunofluorescence studies with the rabbit antisera suggest that the protein is in the plasma membrane. Thus, this protein could be the lymphocyte-determined membrane antigen (LYDMA) responsible for the generation of T-cell immunity to latently infected cells.

MeSH Terms
Cell Membrane/immunology Cell Transformation, Viral Escherichia coli Herpesvirus 4, Human/genetics,immunology Membrane Proteins/genetics,immunology Molecular Weight Protein Conformation Solubility Viral Proteins/genetics,immunology
Chemicals
Membrane Proteins Viral Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hennessy K
Fennewald S
Hummel M
Cole T
Kieff E
References (32)
32 references, click to expand
  1. Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.
    Int J Cancer. 1968 Nov 15;3(6):857-66 PMID: 4894385
  2. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.
    J Virol. 1967 Oct;1(5):1045-51 PMID: 4912237
  3. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  4. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.
    Proc Natl Acad Sci U S A. 1974 Aug;71(8):3283-6 PMID: 4369887
  5. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622-6 PMID: 165518
  6. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    J Virol. 1976 Jun;18(3):1071-80 PMID: 178913
  7. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
    Intervirology. 1975;5(6):319-34 PMID: 181343
  8. Primary structure of alpha-subunit of DNA-dependent RNA polymerase from Escherichia coli.
    FEBS Lett. 1977 Apr 1;76(1):108-11 PMID: 323055
  9. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  10. A new tumour-derived transforming strain of Epstein-Barr virus.
    Nature. 1978 Apr 13;272(5654):629-31 PMID: 205793
  11. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells.
    Nature. 1980 Feb 28;283(5750):865-7 PMID: 6244495
  12. Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line.
    Virology. 1980 Mar;101(2):553-7 PMID: 6244705
  13. Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping.
    Proc Natl Acad Sci U S A. 1980 May;77(5):2999-3003 PMID: 6248879
  14. Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.
    Nature. 1979 Oct 25;281(5733):694-6 PMID: 551290
  15. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    J Virol. 1980 Nov;36(2):506-18 PMID: 6253674
  16. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):4247-50 PMID: 6254017
  17. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells.
    J Virol. 1981 May;38(2):632-48 PMID: 6264134
  18. Protein localization in E. coli: is there a common step in the secretion of periplasmic and outer-membrane proteins?
    Cell. 1981 Jun;24(3):707-17 PMID: 6788377
  19. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.
    Anal Biochem. 1981 Apr;112(2):195-203 PMID: 6266278
  20. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Cancer Res. 1981 Nov;41(11 Pt 1):4253-61 PMID: 6272971
  21. Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection.
    Proc Natl Acad Sci U S A. 1982 Sep;79(18):5698-702 PMID: 6291060
  22. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
    Cell. 1982 Sep;30(2):415-25 PMID: 6291768
  23. Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections.
    J Virol. 1982 Oct;44(1):311-20 PMID: 6292493
  24. Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus.
    J Virol. 1983 Jun;46(3):800-7 PMID: 6304342
  25. Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen.
    Science. 1983 Jun 24;220(4604):1396-8 PMID: 6304878
  26. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.
    Proc Natl Acad Sci U S A. 1983 Sep;80(18):5665-9 PMID: 6310587
  27. Beta-galactosidase gene fusions for analyzing gene expression in escherichia coli and yeast.
    Methods Enzymol. 1983;100:293-308 PMID: 6312261
  28. Sequence of the lacZ gene of Escherichia coli.
    EMBO J. 1983;2(4):593-7 PMID: 6313347
  29. Use of gene fusions and protein-protein interaction in the isolation of a biologically active regulatory protein: the replication initiator protein of plasmid R6K.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6848-52 PMID: 6316329
  30. Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.
    J Virol. 1984 Jan;49(1):132-41 PMID: 6361277
  31. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
    J Virol. 1984 Aug;51(2):411-9 PMID: 6086953
  32. CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).
    Lancet. 1964 Feb 1;1(7327):238-40 PMID: 14086209
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1984-11-00
Pages
7207-11
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC392107
Subset
IM
Grants
NCI NIH HHS · CA 17281 · United States
NCI NIH HHS · CA 19264 · United States
NIGMS NIH HHS · GM 07183 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]